Celsius (NASDAQ:CELH) Given New $48.00 Price Target at JPMorgan Chase & Co.

Key Points

• JPMorgan cut Celsius’s price target from $52 to $48 while maintaining an “overweight” rating, implying approximately 72.8% upside from the stock’s $27.77 price.
• Analyst sentiment remains generally positive, with 14 buy ratings, six holds and one sell; the consensus rating is “Moderate Buy” with an average price target of $41.53.
• Celsius recently missed quarterly expectations, reporting $0.36 in EPS versus $0.41 expected and revenue of $817.93 million versus $870.08 million forecast, while insiders purchased 66,000 shares worth $1.83 million over the past 90 days.

Celsius (NASDAQ:CELH - Get Free Report) had its target price cut by JPMorgan Chase & Co. from $52.00 to $48.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s price objective indicates a potential upside of 72.82% from the stock's current price.

CELH has been the topic of several other research reports. Stephens cut their price target on Celsius from $65.00 to $50.00 and set an "overweight" rating on the stock in a research note on Monday, August 10th. Maxim Group cut Celsius from a "buy" rating to a "hold" rating in a research note on Friday, August 7th. UBS Group set a $38.00 target price on Celsius in a report on Thursday, October 15th. Sanford C. Bernstein cut Celsius from an "outperform" rating to a "market perform" rating and cut their target price for the stock from $44.00 to $26.00 in a research note on Friday, August 7th. Finally, Piper Sandler restated an "overweight" rating and set a $36.00 price target on shares of Celsius in a report on Monday, August 24th. Fourteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $41.53.

Celsius Stock Down 2.4%

NASDAQ CELH traded down $0.69 during trading hours on Monday, reaching $27.77. 1,753,412 shares of the company's stock traded hands, compared to its average volume of 7,783,325. Celsius has a 52-week low of $23.56 and a 52-week high of $64.14. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.80 and a quick ratio of 1.42. The firm has a 50-day simple moving average of $29.41 and a 200 day simple moving average of $30.16. The firm has a market cap of $7.03 billion, a PE ratio of 115.55, a PEG ratio of 2.06 and a beta of 1.01.

Celsius (NASDAQ:CELH - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.36 earnings per share for the quarter, missing analysts' consensus estimates of $0.41 by ($0.05). Celsius had a return on equity of 36.52% and a net margin of 4.24%. The business had revenue of $817.93 million during the quarter, compared to analysts' expectations of $870.08 million. During the same quarter last year, the company posted $0.47 EPS. Celsius's revenue for the quarter was up 10.6% compared to the same quarter last year. Sell-side analysts anticipate that Celsius will post 1.42 EPS for the current fiscal year.

Insider Buying and Selling

In other Celsius news, Director Hal Kravitz bought 12,000 shares of the firm's stock in a transaction on Tuesday, September 15th. The stock was acquired at an average price of $28.00 per share, with a total value of $336,000.00. Following the transaction, the director owned 239,158 shares in the company, valued at $6,696,424. This represents a 5.28% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO John Fieldly bought 18,000 shares of the stock in a transaction on Thursday, September 10th. The shares were bought at an average price of $27.44 per share, for a total transaction of $493,920.00. Following the purchase, the chief executive officer directly owned 956,063 shares in the company, valued at approximately $26,234,368.72. This trade represents a 1.92% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders acquired 66,000 shares of company stock worth $1,830,120. 2.33% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Ranger Investment Management L.P. purchased a new stake in Celsius in the second quarter worth about $13,629,000. Maven Securities LTD bought a new position in shares of Celsius in the second quarter worth about $1,192,000. Fifth Third Bancorp lifted its position in shares of Celsius by 4,648.1% during the 1st quarter. Fifth Third Bancorp now owns 92,873 shares of the company's stock valued at $3,295,000 after buying an additional 90,917 shares in the last quarter. Sovran Advisors LLC purchased a new position in shares of Celsius during the 1st quarter valued at about $1,895,000. Finally, Bank of America Corp DE grew its stake in shares of Celsius by 29.2% during the 2nd quarter. Bank of America Corp DE now owns 656,684 shares of the company's stock valued at $19,228,000 after acquiring an additional 148,432 shares during the period. 60.95% of the stock is owned by hedge funds and other institutional investors.

About Celsius

Celsius Holdings, Inc NASDAQ: CELH develops, markets and distributes functional beverages designed to support active lifestyles. Its flagship CELSIUS brand offers carbonated and non-carbonated energy drinks, including products positioned around energy, fitness and wellness. The company also markets CELSIUS Essentials, CELSIUS Vibe and powdered drink mixes, with product formulations that commonly feature ingredients such as caffeine, vitamins and other functional components.

Founded in 2004, Celsius has expanded from a niche fitness beverage business into a broader energy-drink platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.